181 related articles for article (PubMed ID: 38064101)
1. BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1.
Cao Y; Wang X; Liu Y; Liu P; Qin J; Zhu Y; Zhai S; Jiang Y; Liu Y; Han L; Luo J; Zhang R; Shi M; Wang L; Tang X; Xue M; Liu J; Wang W; Wen C; Deng X; Peng C; Chen H; Cheng D; Jiang L; Shen B
Adv Sci (Weinh); 2024 Feb; 11(7):e2306298. PubMed ID: 38064101
[TBL] [Abstract][Full Text] [Related]
2. BHLHE40, a potential immune therapy target, regulated by FGD5-AS1/miR-15a-5p in pancreatic cancer.
Qi W; Liu Q; Fu W; Shi J; Shi M; Duan S; Li Z; Song S; Wang J; Liu Y
Sci Rep; 2023 Sep; 13(1):16400. PubMed ID: 37773521
[TBL] [Abstract][Full Text] [Related]
3. BHLHE40, a third transcription factor required for insulin induction of SREBP-1c mRNA in rodent liver.
Tian J; Wu J; Chen X; Guo T; Chen ZJ; Goldstein JL; Brown MS
Elife; 2018 Jun; 7():. PubMed ID: 29952285
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells.
Asanoma K; Liu G; Yamane T; Miyanari Y; Takao T; Yagi H; Ohgami T; Ichinoe A; Sonoda K; Wake N; Kato K
Mol Cell Biol; 2015 Dec; 35(24):4096-109. PubMed ID: 26391953
[TBL] [Abstract][Full Text] [Related]
5. Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer.
Li LY; Yang Q; Jiang YY; Yang W; Jiang Y; Li X; Hazawa M; Zhou B; Huang GW; Xu XE; Gery S; Zhang Y; Ding LW; Ho AS; Zumsteg ZS; Wang MR; Fullwood MJ; Freedland SJ; Meltzer SJ; Xu LY; Li EM; Koeffler HP; Lin DC
Nat Commun; 2021 Jul; 12(1):4362. PubMed ID: 34272396
[TBL] [Abstract][Full Text] [Related]
6. Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40.
Yin Y; Xin Y; Zhang F; An D; Fan H; Qin M; Xia J; Xi T; Xiong J
Neoplasia; 2023 May; 39():100891. PubMed ID: 36931039
[TBL] [Abstract][Full Text] [Related]
7. SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer.
Audet-Walsh É; Vernier M; Yee T; Laflamme C; Li S; Chen Y; Giguère V
Mol Cancer Res; 2018 Sep; 16(9):1396-1405. PubMed ID: 29784665
[TBL] [Abstract][Full Text] [Related]
8. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment.
Wang L; Liu Y; Dai Y; Tang X; Yin T; Wang C; Wang T; Dong L; Shi M; Qin J; Xue M; Cao Y; Liu J; Liu P; Huang J; Wen C; Zhang J; Xu Z; Bai F; Deng X; Peng C; Chen H; Jiang L; Chen S; Shen B
Gut; 2023 May; 72(5):958-971. PubMed ID: 35688610
[TBL] [Abstract][Full Text] [Related]
10. Interaction with SP1, but not binding to the E-box motifs, is responsible for BHLHE40/DEC1-induced transcriptional suppression of CLDN1 and cell invasion in MCF-7 cells.
Zheng Q; Wang C; Wang L; Zhang D; Liu N; Ming X; Zhou H; Guli Q; Liu Y
Mol Carcinog; 2018 Sep; 57(9):1116-1129. PubMed ID: 29704436
[TBL] [Abstract][Full Text] [Related]
11. BHLHE40 plays a pathological role in pre-eclampsia through upregulating SNX16 by transcriptional inhibition of miR-196a-5p.
Mi C; Ye B; Gao Z; Du J; Li R; Huang D
Mol Hum Reprod; 2020 Jul; 26(7):532-548. PubMed ID: 32579212
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells.
Kanda M; Yamanaka H; Kojo S; Usui Y; Honda H; Sotomaru Y; Harada M; Taniguchi M; Suzuki N; Atsumi T; Wada H; Baghdadi M; Seino K
Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3394-402. PubMed ID: 27226296
[TBL] [Abstract][Full Text] [Related]
13. Bhlhe40 Represses PGC-1α Activity on Metabolic Gene Promoters in Myogenic Cells.
Chung SY; Kao CH; Villarroya F; Chang HY; Chang HC; Hsiao SP; Liou GG; Chen SL
Mol Cell Biol; 2015 Jul; 35(14):2518-29. PubMed ID: 25963661
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.
Yi J; Zhu J; Wu J; Thompson CB; Jiang X
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31189-31197. PubMed ID: 33229547
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of INHBA mediated by the transcription factor BHLHE40 promotes colon cancer cell proliferation and migration.
Wang J; Li B; Yang S; Ma C; Liu K; Chen X; Cui W
J Clin Lab Anal; 2022 Jul; 36(7):e24539. PubMed ID: 35689549
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia Inhibits Myogenic Differentiation through p53 Protein-dependent Induction of Bhlhe40 Protein.
Wang C; Liu W; Liu Z; Chen L; Liu X; Kuang S
J Biol Chem; 2015 Dec; 290(50):29707-16. PubMed ID: 26468276
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone induces cellular senescence in prostate cancer cells through induction of DEC1.
Kotolloshi R; Mirzakhani K; Ahlburg J; Kraft F; Pungsrinont T; Baniahmad A
J Steroid Biochem Mol Biol; 2020 Jul; 201():105689. PubMed ID: 32360904
[TBL] [Abstract][Full Text] [Related]
18. BHLHE40 Regulates IL-10 and IFN-
Uyeda MJ; Freeborn RA; Cieniewicz B; Romano R; Chen PP; Liu JM; Thomas B; Lee E; Cepika AM; Bacchetta R; Roncarolo MG
Front Immunol; 2021; 12():683680. PubMed ID: 34305917
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia causes pancreatic β-cell dysfunction and impairs insulin secretion by activating the transcriptional repressor BHLHE40.
Tsuyama T; Sato Y; Yoshizawa T; Matsuoka T; Yamagata K
EMBO Rep; 2023 Aug; 24(8):e56227. PubMed ID: 37341148
[TBL] [Abstract][Full Text] [Related]
20. The gene for the transcription factor BHLHE40/DEC1/stra13 is a dynamically regulated primary target of the vitamin D receptor.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
J Steroid Biochem Mol Biol; 2013 Jul; 136():62-7. PubMed ID: 23220548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
